Company: MDCXW
Filing Date: 2025-07-23
Form Type: 424B3
Source: 0001062993-25-013080
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-07-23
Form: 424B3
Chunk 4
---
 between the Company and YA II PN, Ltd. of common shares representing 20% or more of the issued and outstanding common shares prior to such issuance at prices below the minimum price specified by Nasdaq Listing Rule 5635(d), which required the affirmative vote of at least a majority of the votes cast by the shareholders present at the Meeting in person or by proxy:

| For        |     | Against |     | Abstain |     | Broker Non-Votes |
| 10,063,947 |     |  68,728 |     | N/A     |     |        3,185,015 |

Proposal 5. Shareholders approved the proposal to amend the Articles to increase the voting threshold required to remove the Chairman of the Board to a vote of at least 75% of the Board and to make this provision part of the Articles, which required the affirmative vote of at least two-thirds of the votes cast by the shareholders present at the Meeting in person or by proxy:

| For       |     | Against |     | Abstain |     | Broker Non-Votes |
| 9,891,337 |     | 241,338 |     | N/A     |     |        3,185,015 |

SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               | Dr. Raza Bokhari                               |
| Title:              | Executive Chairman and Chief Executive Officer |

Dated: July 23, 2025